Huntingtin-protein interactions and the pathogenesis of Huntington's disease
- PMID: 15036808
- DOI: 10.1016/j.tig.2004.01.008
Huntingtin-protein interactions and the pathogenesis of Huntington's disease
Abstract
At least nine inherited neurodegenerative diseases share a polyglutamine expansion in their respective disease proteins. These diseases show distinct neuropathological changes, suggesting that protein environment and protein-protein interactions play an important role in the specific neuropathology. A gain of toxic function as a result of an expanded polyglutamine tract can cause the protein huntingtin to interact abnormally with a variety of proteins, resulting in the complex of neuropathological changes seen in Huntington's disease. Recent studies have identified several huntingtin-interacting proteins that might be associated with the normal function of huntingtin and/or involved in the pathology of Huntington's disease. In this article, we focus on the potential roles of huntingtin-protein interactions in the pathogenesis of Huntington's disease.
Similar articles
-
Nucleocytoplasmic trafficking and transcription effects of huntingtin in Huntington's disease.Prog Neurobiol. 2007 Nov;83(4):211-27. doi: 10.1016/j.pneurobio.2006.11.004. Epub 2007 Jan 22. Prog Neurobiol. 2007. PMID: 17240517 Review.
-
Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin.Proc Natl Acad Sci U S A. 1996 May 14;93(10):5037-42. doi: 10.1073/pnas.93.10.5037. Proc Natl Acad Sci U S A. 1996. PMID: 8643525 Free PMC article.
-
Molecular aspects of Huntington's disease.J Neurosci Res. 1998 Nov 1;54(3):301-8. doi: 10.1002/(SICI)1097-4547(19981101)54:3<301::AID-JNR1>3.0.CO;2-W. J Neurosci Res. 1998. PMID: 9819135 Review.
-
Hypothesis: Huntingtin may function in membrane association and vesicular trafficking.Biochem Cell Biol. 2006 Dec;84(6):912-7. doi: 10.1139/o06-181. Biochem Cell Biol. 2006. PMID: 17215878 Review.
-
Huntington's disease--making connections.N Engl J Med. 2007 Feb 1;356(5):518-20. doi: 10.1056/NEJMcibr067022. N Engl J Med. 2007. PMID: 17267914 No abstract available.
Cited by
-
Global profiling of protein complex dynamics with an experimental library of protein interaction markers.Nat Biotechnol. 2024 Oct 16. doi: 10.1038/s41587-024-02432-8. Online ahead of print. Nat Biotechnol. 2024. PMID: 39415059
-
Extracellular vesicle therapy in neurological disorders.J Biomed Sci. 2024 Aug 25;31(1):85. doi: 10.1186/s12929-024-01075-w. J Biomed Sci. 2024. PMID: 39183263 Free PMC article. Review.
-
Exploring molecular mechanisms, therapeutic strategies, and clinical manifestations of Huntington's disease.Arch Pharm Res. 2024 Jun;47(6):571-595. doi: 10.1007/s12272-024-01499-w. Epub 2024 May 19. Arch Pharm Res. 2024. PMID: 38764004 Review.
-
Understanding the prion-like behavior of mutant p53 proteins in triple-negative breast cancer pathogenesis: The current therapeutic strategies and future directions.Heliyon. 2024 Feb 10;10(4):e26260. doi: 10.1016/j.heliyon.2024.e26260. eCollection 2024 Feb 29. Heliyon. 2024. PMID: 38390040 Free PMC article. Review.
-
Targeting Progranulin as an Immuno-Neurology Therapeutic Approach.Int J Mol Sci. 2023 Nov 3;24(21):15946. doi: 10.3390/ijms242115946. Int J Mol Sci. 2023. PMID: 37958929 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
